Pharmacogenomic predictors of proton pump inhibitor response in pediatric eosinophilic esophagitis
Frontiers in Pharmacology · 30.10.2026 · 17
DOI: 10.3389/fphar.2026.1913372 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 30.10.2026. Verfasst von Mariamena Arbitrio und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department for the Promotion of Human Science and Quality of Life, San Raffaele Roma University, Rome, Italy. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Genetic variability has been implicated in the heterogeneous response to proton pump inhibitors (PPIs) in eosinophilic esophagitis (EoE), with variants in CYP2C19 and STAT6 previously associated with treatment outcome. However, the broader pharmacogenomic determinants underlying interindividual variability in PPI response remain incompletely understood.
Methods
This study aimed to investigate whether genetic variability in Absorption, Distribution, Metabolism, and Excretion (ADME) genes contributes to PPI response in pediatric EoE. Fifty-eight patients (17 responders, PPI-RE, and 41 non-responders, PPI-NORE) were genotyped using the Drug Metabolizing Enzymes and Transporters (DMET) Plus microarray, covering 231 ADME-related genes. Genetic and clinical data were integrated using a machine learning–based approach to explore determinants of treatment response.
Results
CHST3 rs4148944 G/G genotype showed the strongest nominal association with PPI response (p < 0.0064). Integrative analysis revealed combinatorial patterns involving CHST3, CHST11 gene ( rs7847 ), SULT1A2/A3 ( rs11859842 ), and NR1I3 ( rs55802895 ), particularly in the presence of food allergy, which improved patient stratification. Although these additional variants were not individually significant, their combined occurrence—especially in association with food allergy—suggests a potential contribution of both metabolic and regulatory pathways to PPI response variability.
Conclusion
Overall, this study provides exploratory, proof-of-concept evidence that the CHST3 rs4148944 G/G genotype, together with other genetic variants and clinical features, may influence PPI response in EoE and contribute to patient stratification. These findings support the potential of integrative pharmacogenomic approaches, although validation in larger cohorts is required.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department for the Promotion of Human Science and Quality of Life, San Raffaele Roma University, Rome, Italy.
- Institute for Biomedical Research and Innovation, National Research Council (CNR), Catanzaro, Italy.
- Gastroenterology and Nutrition Unit, Bambino Gesù Children's Hospital, IRCS, Rome, Italy.
- Pediatric Unit,"Renato Dulbecco" University Hospital, Magna Graecia University (UMG), Catanzaro, Italy.
- Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy.
- Department of Legal, Economic and Social Sciences, Magna Graecia University, Catanzaro, Italy.
Zitieren
APA
Arbitrio, M., Tambucci, R., Tallarico, V., Gnasso, I., Scionti, F., Agapito, G., Altomare, E., Cannataro, M., D'Arrigo, G., Tripepi, G., Concolino, D., De Masi, F., Puoti, M. G., Rea, F., Malamisura, M., Ricci, A. M., Artesani, M. C., Urbani, S., Calandrelli, V., …, & Pensabene, L. (2026). Pharmacogenomic predictors of proton pump inhibitor response in pediatric eosinophilic esophagitis. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1913372
Vancouver
Arbitrio M, Tambucci R, Tallarico V, Gnasso I, Scionti F, Agapito G, et al. Pharmacogenomic predictors of proton pump inhibitor response in pediatric eosinophilic esophagitis. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1913372
BibTeX
@article{Arbitrio2026,
author = {Arbitrio, Mariamena and Tambucci, Renato and Tallarico, Valeria and Gnasso, Ilaria and Scionti, Francesca and Agapito, Giuseppe and Altomare, Emanuela and Cannataro, Mario and D'Arrigo, Graziella and Tripepi, Giovanni and Concolino, Daniela and De Masi, Fabiola and Puoti, Maria Giovanna and Rea, Francesca and Malamisura, Monica and Ricci, Alessandra Maria and Artesani, Maria Cristina and Urbani, Sara and Calandrelli, Veronica and Fiocchi, Alessandro Giovanni and De Angelis, Paola and Pensabene, Licia},
title = {Pharmacogenomic predictors of proton pump inhibitor response in pediatric eosinophilic esophagitis},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1913372}
}
EUVIMED